Literature DB >> 24825041

Reverse shoulder arthroplasty using a "L" shaped allograft for glenoid reconstruction in a patient with massive glenoid bone loss: case report.

C F De Biase1, G Ziveri, F De Caro, N Roberts, M Delcogliano.   

Abstract

Primary reverse total shoulder arthroplasty (RSA) has demonstrated to relieve pain, restore function and active elevation in patients with Cuff Tear Arthropathy. This condition of muscular imbalance could lead, in the long-term, to morphologic changes of the glenoid's anatomy. Insufficient bone stock of glenoid is a major challenge and without reconstruction, may be inadequate to support a glenoid component. Many authors have proposed the use of a bone graft in these cases and different techniques have been described to reconstruct severe bone loss of the glenoid but no ideal approach has currently been identified. We report the use of a "L" shaped frozen allograft for glenoid reconstruction in a patient with massive, uncontained glenoid bone loss, undergoing a reverse shoulder arthroplasty in a "one step" procedure. At 1-year follow-up both x-rays and CT showed graft incorporation with no resorption of bone and the patient reported continued stability of the shoulder and a high-level of satisfaction in terms of pain and function.

Entities:  

Mesh:

Year:  2014        PMID: 24825041

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  Bone grafting in primary and revision reverse total shoulder arthroplasty for the management of glenoid bone loss: A systematic review.

Authors:  Michael-Alexander Malahias; Dimitrios Chytas; Lazaros Kostretzis; Emmanouil Brilakis; Emmanouil Fandridis; Michael Hantes; Emmanouil Antonogiannakis
Journal:  J Orthop       Date:  2019-12-10

2.  Effect of complications on outcomes after revision reverse total shoulder arthroplasty.

Authors:  Robert Z Tashjian; Erin Granger; Kortnie Broschinsky; Jun Kawakami; Peter N Chalmers
Journal:  JSES Int       Date:  2020-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.